Coverage
-
April 23, 2020
Incarcerated "pharma bro" Martin Shkreli and his former company Retrophin Inc. have managed to slip claims that they tried to keep a generic competitor to their kidney drug Thiola out of the market, as the would-be rival quietly dropped its suit Wednesday.
3 other articles on this case.
View all »